tumCV Cancer Research Results
tumCV, Cell Viability: Click to Expand ⟱
| Source: |
| Type: |
Cell Viability
|
RCC, Renal cell Carcinoma: Click to Expand ⟱
Renal cell carcinoma (RCC) is one of the most common malignant tumors of the urinary system, accounting for 80–90% of kidney neoplasms.
The activation of the mTOR pathway has been found in RCC and is correlated with high grade and poor prognostic patient features (41,42).
|
Scientific Papers found: Click to Expand⟱
Dose∅, Apoptosis↑, Casp↑, tumCV↓, Casp3↑, Casp7↑, Ca+2↑, Cyt‑c↑,
tumCV↓, Apoptosis↑, P53↑, BAX↑, Cyt‑c↑, cl‑Casp9↑, cl‑Casp3↑, cl‑PARP↑, Bcl-2↓, Bcl-xL↓, p‑STAT3↓, p‑JAK2↓, STAT3↓, survivin↓, cycD1/CCND1↓, ROS↑, eff↓,
tumCV↓, ROS↑, TumCCA↑, eff↓, TumCI↓,
TET2↑, TumCG↓, tumCV↓,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
ROS↑, 2,
Cell Death ⓘ
Apoptosis↑, 2, BAX↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp↑, 1, Casp3↑, 1, cl‑Casp3↑, 1, Casp7↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 2, survivin↓, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 4,
DNA Damage & Repair ⓘ
P53↑, 1, cl‑PARP↑, 1,
Cell Cycle & Senescence ⓘ
cycD1/CCND1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
STAT3↓, 1, p‑STAT3↓, 1, TumCG↓, 1,
Migration ⓘ
Ca+2↑, 1, TumCI↓, 1,
Immune & Inflammatory Signaling ⓘ
p‑JAK2↓, 1,
Drug Metabolism & Resistance ⓘ
Dose∅, 1, eff↓, 2, TET2↑, 1,
Total Targets: 26
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: tumCV, Cell Viability
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:24 Cells:% prod#:% Target#:897 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page